Medical Weight Loss in Chattanooga: The Physician-Led Difference
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
If you’ve searched “medical weight loss Chattanooga,” you’ve probably found a lot of the same thing: a stock photo of a smiling provider, a quiz that takes two minutes, and a subscription box on the way. I practice emergency medicine at a hospital in this city. I also built Summit Metabolic Health here, in Signal Mountain, because I got tired of watching what happens after people go through that exact funnel with no one actually reading their chart.
I’m not against GLP-1 medications. I prescribe them. What I’m against is the version of “medical” that means a form, not a physician. Here’s the honest difference, and what the evidence actually supports.
Most DTC weight-loss telehealth companies — Ro, Hims, Calibrate, Found, Henry Meds — run on the same structural model: an intake questionnaire, an algorithm or a nurse-practitioner queue, and a prescription that follows a protocol, not a person. None of them are physician-led. That’s not marketing language on my part — it’s how their own intake flows are built.
At Summit, I read every chart myself. Not a summary. Not a flag an algorithm kicked up for review. Your history, your labs, your medication list — I look at it before you start, and I look at it again at every dose change. That’s the entire reason I read every chart myself: because a checkbox you click yourself is not the same as a physician reviewing your actual history.
This matters more than it sounds like it should. GLP-1 medications are powerful, and they’re not risk-free. Dose titration, GI side effects, drug interactions, and knowing when not to prescribe are all judgment calls. An algorithm doesn’t make judgment calls. A physician does.
Semaglutide and tirzepatide work on the biology of appetite, not on willpower. You did not fail every diet because you lacked discipline. These medications mimic hormones your gut already releases after eating — they slow gastric emptying so you feel full longer, they act on receptors in your brain that regulate hunger and satiety, and they improve how your body releases insulin in response to glucose.
In plain terms: the constant background noise of thinking about your next meal — patients call it “food noise” — quiets down. Cravings that used to run the show all day start to fade into the background. For a lot of people, that’s the first time appetite hasn’t felt like something they’re fighting.
Tirzepatide adds a second mechanism on top of that, acting on both the GLP-1 receptor and the GIP receptor, which is part of why its trial data runs slightly ahead of semaglutide’s on average. Both medications are prescription drugs that require dose titration and monitoring — not a supplement, not a shortcut.
I’d rather you hear the real numbers from me than a rounded-up version from an ad.
The STEP 1 trial (Wilding et al., NEJM, 2021) followed adults on semaglutide 2.4mg for 68 weeks. The semaglutide group lost a mean of 14.9% of body weight, compared to 2.4% in the placebo group.
The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) followed adults on tirzepatide for 72 weeks. At the highest studied dose, 15mg, the mean weight loss reached 20.9%.
Read those numbers carefully. These are group averages from randomized controlled trials. They are not a promise about you specifically. Some patients lose more, some lose less, and response depends on dose, adherence, and individual biology. Results vary — and any program that shows you a number without that caveat is not being straight with you.
Here’s where we won’t sugarcoat it: pricing in this industry is built to confuse you. Hims lists GLP-1 access starting around $448/month. Ro runs $349–$498/month. Henry Meds runs $297–$399/month. Several of these also carry a price cliff after an introductory period — the number you see in the ad isn’t the number you pay by month four.
Summit’s pricing is descending-dose transparent, all-in: $175–$225/month, published, no “starting at” asterisk, no post-onboarding jump. You can buy semaglutide or tirzepatide from a lot of places. What’s harder to find — here in Chattanooga or anywhere — is a program that tells you the real number up front and a board-certified physician who reads your chart before you pay it.
Not one of the DTC competitors above currently has a page built for Chattanooga specifically. That’s worth noting, because it tells you something about how they think about local care: they don’t, structurally. It’s a national funnel with a city name inserted.
This is the part nobody sees in a stock-photo ad. Every patient’s chart gets reviewed by me before their first prescription — not after. Every dose change goes through the same review, not an automated escalation. If you report a side effect, that goes to a physician’s judgment, not a script that tells the intake coordinator what to say next.
I’m an ER physician by training, so I pay close attention to your heart and your overall history, not just the number on the scale. That habit doesn’t turn off when I’m not on shift. Safety monitoring, lab checks at the intervals that matter, and a maintenance plan for after you hit goal — that’s what oversight is supposed to mean, and it’s what a checkbox intake structurally cannot provide.
It isn’t right for everyone. These medications aren’t appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, active gallbladder disease that hasn’t been addressed, or if you’re pregnant or trying to become pregnant. Common side effects — nausea, constipation, reduced appetite — are real, most pronounced during dose escalation, and manageable with the right titration and support. I tell patients plainly: don’t judge the medication by week one.
The trials are also blunt about what happens after you stop. A significant share of lost weight tends to return once the medication is discontinued without a plan. That’s why Summit is built around an exit strategy from day one, not an afterthought once you hit goal.
If you’ve been failed by diets before, that wasn’t a willpower problem — it was a biology problem nobody explained to you clearly. The honest first step is a real conversation with a physician who will tell you what this can and can’t do for your specific history, before you spend a dollar.
Ready to start? Apply at summitmetabolichealth.com/apply
This content is for educational purposes and does not constitute medical advice. GLP-1 medications require a physician evaluation to determine appropriateness for your individual health history. Individual results vary; trial data represent group averages, not guaranteed outcomes.
